Tolterodine and its active 5-hydroxymethyl metabolite: pure muscarinic receptor antagonists (Q44036364)

29 November 2017

title

Tolterodine and its active 5-hydroxymethyl metabolite: pure muscarinic receptor antagonists (English)

1 reference

29 November 2017

Lisbeth Nilvebrant

1

1 reference

29 November 2017

publication date

1 May 2002

1 reference

Basic and Clinical Pharmacology and Toxicology

29 November 2017

published in

1 reference

29 November 2017

volume

90

1 reference

29 November 2017

issue

5

1 reference

29 November 2017

page(s)

260-267

1 reference

Current concepts in the treatment of disorders of micturition

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.900506.X

Differential effects of the enantiomers R(-) and S(+) oxaprotiline on major endogenous depression, the sleep EEG and neuroendocrine secretion: studies on depressed patients and normal controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.900506.X

"Calcium antagonists": a class of drugs with a bright future. Part I. Cellular calcium homeostasis and calcium as a coupling messenger.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.900506.X

Effects of vitamin D (calcitriol) on transitional cell carcinoma of the bladder in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.900506.X

Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.900506.X

Heterogeneity of [3H]-mepyramine binding sites in guinea pig cerebellum and lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.900506.X

Specific Pharmacology of Calcium in Myocardium, Cardiac Pacemakers, and Vascular Smooth Muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.900506.X

A comparison of several calcium antagonists on uterine, vascular and cardiac muscles from the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.900506.X

Binding characteristics of 3H-prazosin to rat brain α-adrenergic receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.900506.X

Tolterodine in the treatment of overactive bladder: analysis of the pooled phase II efficacy and safety data

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.900506.X

High affinity specific [3H] (+)PN 200-110 binding to dihydropyridine receptors associated with calcium channels in rat cerebral cortex and heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.900506.X

Torsades de pointes complicating treatment with terodiline

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.900506.X

Clinical experiences with tolterodine

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.900506.X

Antimuscarinic potency and bladder selectivity of PNU-200577, a major metabolite of tolterodine

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.900506.X

Tolterodine--a new bladder selective muscarinic receptor antagonist: preclinical pharmacological and clinical data

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.900506.X

Rat hippocampal muscarinic autoreceptors are similar to the M2 (cardiac) subtype: comparison with hippocampal M1, atrial M2 and ileal M3 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.900506.X

Reversible and irreversible labeling and autoradiographic localization of the cerebral histamine H2 receptor using [125I]iodinated probes

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.900506.X

Urodynamic and other effects of tolterodine: a novel antimuscarinic drug for the treatment of detrusor overactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.900506.X

Inhibitory effects of propiverine on rat and guinea-pig urinary bladder muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.900506.X

Rat spinal cord alpha 2-adrenoceptors are of the alpha 2A-subtype: comparison with alpha 2A- and alpha 2B-adrenoceptors in rat spleen, cerebral cortex and kidney using 3H-RX821002 ligand binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.900506.X

Oxybutynin. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in detrusor instability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.900506.X

Tolterodine, a new antimuscarinic agent: as effective but better tolerated than oxybutynin in patients with an overactive bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.900506.X

7 January 2021

Clinical efficacy and safety of tolterodine in the treatment of overactive bladder: a pooled analysis

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.900506.X

7 January 2021

Torsades de pointes ventricular tachycardia and terodiline

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.900506.X

7 January 2021

On the pharmacokinetics and metabolism of propiverine in man

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.900506.X

7 January 2021

Measurement of oxybutynin and its N-desethyl metabolite in plasma, and its application to pharmacokinetic studies in young, elderly and frail elderly volunteers

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.900506.X

7 January 2021

[Effects of propiverine hydrochloride (propiverine) on isolated rat and dog urinary bladder].

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.900506.X

7 January 2021

A medium-term analysis of the subjective efficacy of treatment for women with detrusor instability and low bladder compliance.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.900506.X

7 January 2021

Kinetics of propiverine as assessed by radioreceptor assay in poor and extensive metabolizers of debrisoquine

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.900506.X

7 January 2021

Cardiac versus vascular effects of a new dihydropyridine derivative, CV-4093. In vitro comparison with other calcium antagonists

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.900506.X

7 January 2021

Tolterodine--a new bladder-selective antimuscarinic agent

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.900506.X

7 January 2021

Serum protein binding of tolterodine and its major metabolites in humans and several animal species

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.900506.X

7 January 2021

Negative inotropic properties of isradipine, nifedipine, diltiazem, and verapamil in diseased human myocardial tissue

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.900506.X

7 January 2021

Terodiline causes polymorphic ventricular tachycardia due to reduced heart rate and prolongation of QT interval

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.900506.X

7 January 2021

Omega-conotoxin GVIA binding to a high-affinity receptor in brain: characterization, calcium sensitivity, and solubilization

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.900506.X

7 January 2021

Comparison of oxybutynin and its active metabolite, N-desethyl-oxybutynin, in the human detrusor and parotid gland

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.900506.X

7 January 2021

Pharmacological effects of tolterodine on human isolated urinary bladder

1 reference

https://api.crossref.org/works/10.1034%2FJ.1600-0773.2002.900506.X

7 January 2021

10.1034/J.1600-0773.2002.900506.X

Identifiers

DOI

1 reference

release_mvcre6hf4bcgxf6qwlsd5ntf6q

29 November 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/mvcre6hf4bcgxf6qwlsd5ntf6q

24 November 2022

mapped directly with Wikidata item

1 reference